BMJ, a global healthcare knowledge provider, has signed an agreement with the State Institute of Health and Family Welfare (SIHFW) to provide leading clinical learning and decision support tools to healthcare professionals across Jaipur, Rajasthan, India.
Nanyang Technological University is spearheading the Natural Catastrophe Data and Analytics Exchange Alliance of leading multinational and regional companies in the insurance industry to enable more countries in Asia to better cope with the economic and financial fallout from natural disasters. It will generate a rigorous database by tapping into national and industry data. Such high quality data, market analytics and product innovations are currently lacking in the region.
Evelo Biosciences and the University of Chicago have announced that they have entered into an exclusive worldwide license agreement to develop and commercialize a microbiome-based cancer immunotherapy. The cancer therapy, developed in the laboratories of Thomas Gajewski, professor of medicine and pathology at UChicago, employs select gut microbes to boost the immune system's attack on cancer cells and improve the efficacy of anti-cancer drugs.
Kennedy Krieger Institute in Baltimore, Md., today helped launch SPARK, an online research initiative designed to become the largest autism study ever undertaken in the United States. Sponsored by the Simons Foundation Autism Research Initiative (SFARI), SPARK will collect information and DNA for genetic analysis from 50,000 individuals with autism -- and their families -- to advance our understanding of the causes of this condition and to hasten the discovery of supports and treatments.
Researchers from the University of Miami - Nova Southeastern University Center for Autism and Related Disabilities (UM-NSU CARD) within the University of Miami (UM) Department of Psychology in Coral Gables, FL, today helped launch SPARK, an online research initiative designed to become the largest autism study ever undertaken in the United States.
University of Leicester researchers will visit Kenya from April 25-29 to start a new climate change initiative.
Drug-carrying 'nanoghosts' that battle melanoma and new treatments for malignant mesothelioma will be the focus of the first joint research projects led by NYU Langone Medical Center and the Technion-Israel Institute of Technology.
There are currently no medications available to specifically treat Lewy Body dementia, and patients are typically treated with medications for Alzheimer's disease. FAU's College of Medicine is spearheading the South Florida site for the first US clinical trial for LBD, the second-most common dementia after Alzheimer's. The HEADWAY-DLB is a phase 2b multi-center, double-blind, placebo-controlled study to evaluate an investigational medicine, RVT-101, for dementia with Lewy bodies.
Griffith University's Climate Change Response Program is part of a remarkable Pacific Island project to rebuild an area devastated by Cyclone Pam in 2015 and enhance its ability to withstand future extreme weather events.
A drone fitted with a thermal camera to monitor buildings' energy efficiency is being developed by students at the University of Strathclyde.